Tirzepatide (GLP-2 T) in Clavicular's Protocol: The Weight Loss Layer
Clavicular's transformation stack is built on three pillars: Retatrutide for maximum fat loss drive, BPC-157/TB-500 for recovery, and GLP-class peptides for metabolic optimization. Tirzepatide (GLP-2 T) represents the dual-agonist entry point into GLP-1/GIP research.
GLP-Class Peptides in the Clavicular Transformation Stack
Clavicular's viral looksmaxxing transformation showcased a multi-peptide research protocol that combined body recomposition, facial structure optimization, and recovery. The fat loss layer of his protocol centers on GLP-class receptor agonists — with Retatrutide (GLP-3 R, the triple agonist) as the primary driver and Tirzepatide (GLP-2 T, the dual agonist) as the research entry point for researchers studying GLP-1/GIP mechanisms specifically.
Both compounds belong to the incretin mimetic class — synthetic peptides designed to activate receptors normally stimulated by endogenous hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Tirzepatide activates two of these three receptors; Retatrutide activates all three (adding glucagon receptor agonism for additional energy expenditure effects).
GLP-Class Peptide Comparison
| Peptide | Receptors | Best Data | Trial |
|---|---|---|---|
| Semaglutide (GLP-1 S) | GLP-1R | −15.3% | STEP-1 |
| Tirzepatide (GLP-2 T) | GLP-1R + GIPR | −20.9% | SURMOUNT-1 |
| Retatrutide (GLP-3 R) | GLP-1R + GIPR + GcgR | −24.2% | Phase 2 |
How Tirzepatide Works: Dual Incretin Mechanism
Tirzepatide is a synthetic 39-amino acid peptide with a C20 fatty diacid side-chain modification enabling extended half-life (~5 days) for once-weekly subcutaneous dosing. It was engineered to activate both GLP-1R and GIPR with approximately equal potency — a design breakthrough compared to earlier biased agonists.
GLP-1R Activation Effects
GLP-1 receptor activation drives glucose-dependent insulin secretion (reducing hyperglycemia risk), delays gastric emptying (prolonging satiety), and activates hypothalamic satiety centers. These effects are documented across the entire class of GLP-1 agonists and are well-established.
GIPR Activation: The Differentiator
GIP receptor activation adds a critical dimension: direct effects on adipocytes (promoting lipolysis during research protocols) and potentially reducing GLP-1-associated nausea through GIP's counterregulatory effects on GLP-1R signaling in the brainstem. GIP receptors are expressed in adipose tissue, hypothalamus, and skeletal muscle — enabling Tirzepatide to impact energy metabolism at multiple tissue levels simultaneously.
For body recomposition research — reducing fat mass while preserving or building lean mass — the dual mechanism provides significant research advantages over GLP-1 monoagonists.
Research-grade GLP-2 T (Tirzepatide) 15mg is available at PeptideScientists.com — the dedicated GLP-1/GIP dual agonist research resource , featuring full SURMOUNT trial breakdowns, GIP receptor biology guides, and reconstitution protocols.
GLP-2 T Research Specifications
Fat Loss and Body Recomposition: The Looksmaxxing Relevance
For researchers studying aesthetic body transformation — the category Clavicular's protocol made famous — body fat percentage and distribution are primary endpoints. Sub-15% body fat is associated with more pronounced facial definition, improved jaw angle visibility, and increased muscularity appearance. Tirzepatide's ability to drive 20%+ weight loss while targeting predominantly fat mass (75%+ of total mass loss in favorable protocols) makes it the most research-validated compound in this space.
The combination of a GLP-class peptide (for fat loss) with BPC-157 and TB-500 (for recovery and tissue integrity) mirrors Clavicular's documented stack rationale — addressing body recomposition and structural tissue health simultaneously.
Available in 15mg, 30mg, and 60mg vials. Full SURMOUNT trial data, dual-agonist mechanism guides, and reconstitution protocols at PeptideScientists — the dedicated Tirzepatide research resource.
GLP-2 T 15mg at PeptideScientists